Associated Papers
Binding of the human complement regulators CFHR1 and factor H by streptococcal collagen-like protein 1 (Scl1) via their conserved C termini allows control of the complement cascade at multiple levels.
Reuter M et al.
The Journal of Biological Chemistry, 2010
The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome.
Ferreira VP et al.
Journal of Immunology (baltimore, Md. : 1950), 2009
Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome.
Jokiranta TS et al.
The Embo Journal, 2006
An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations.
Saunders RE et al.
Human Mutation, 2006
Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions.
Józsi M et al.
Journal of the American Society of Nephrology : Jasn, 2006
Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site.
Jokiranta TS et al.
The American Journal of Pathology, 2005
Factor H binds to washed human platelets.
Vaziri-Sani F et al.
Journal of Thrombosis and Haemostasis : Jth, 2005
Genetic screening in haemolytic uraemic syndrome.
Zipfel PF et al.
Current Opinion in Nephrology and Hypertension, 2003
Select a paper to view details